Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
Worth Seeing!
Raymond Moses: Unleashing the Financial Potential of Billions!
Thyrocare Technologies is coming out with a 100% book building; initial public offering (IPO) of 10,744,708 shares of Rs 10 each in a price band Rs 420-446 per equity share. The issue will open for subscription on April 27, 2016 and will close on April 29, 2016.
The objects of the Offer are to achieve the benefits of listing the Equity Shares on the BSE and the NSE and to carry out the sale of up to 10,744,708 Equity Shares by the Selling Shareholders. The listing of the Equity Shares will enhance the company’s brand name and provide liquidity to the existing Shareholders. The listing of the Equity Shares will also provide a public market for the Equity Shares in India. The company will not receive any proceeds from the Offer.
Not more than 50% of the issue will be allocated to Qualified Institutional Buyers (QIBs), including 5% to the mutual funds. Further, not less than 15% of the issue will be available for the non-institutional bidders and the remaining 35% for the retail investors.
The shares will be listed on BSE as well as NSE. The face value of the share is Rs 10 and is priced 42.00 times of its face value on the lower side and 44.60 times on the higher side.
The book running lead managers to the issue are JM Financial Institutional Securities, Edelweiss Financial Services and ICICI Securities, while the compliance officer for the issue is Ramjee Dorai.
Thyrocare Technologie is one of the leading pan-India diagnostic chains and conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7000.00 |
| Max Healthcare Inst | 1008.35 |
| Narayana Hrudayalay | 1265.30 |
| Aster DM Healthcare | 442.70 |
| Global Health | 1105.25 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
